TCL Archive Board approves continuation of partnerships between minority institutions and cancer centers for research, training, and outreach. July 9, 2004
TCL Archive Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa. January 7, 2005
TCL Archive DCT Board Approves Proposals For Increased Efforts With Biological Response Modifiers, Oks Contracts November 9, 1979
